Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Norovirus capsid protein VP1 is the major structural protein forming the outer shell of noroviruses, including the GI.1 genotype (Norwalk virus). It plays a central role in viral assembly, host cell attachment, immune recognition, and genetic diversity. VP1 self-assembles into an icosahedral capsid and is comprised of Shell (S) and Protruding (P) domains. The P domain is responsible for binding to histo-blood group antigens (HBGAs) on host cells. Variability in the P2 subdomain contributes to immune evasion and strain diversity. VP1 interacts with minor capsid protein VP2 to assist genome encapsidation and regulates viral genome synthesis. It is a target for neutralizing antibodies and vaccine development.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Norovirus Capsid Protein VP1 (GI.1) (VP1).